These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25786238)

  • 1. Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens.
    Reguzova A; Antonets D; Karpenko L; Ilyichev A; Maksyutov R; Bazhan S
    PLoS One; 2015; 10(3):e0116412. PubMed ID: 25786238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches in polyepitope T-cell vaccine development against HIV-1.
    Karpenko LI; Bazhan SI; Antonets DV; Belyakov IM
    Expert Rev Vaccines; 2014 Jan; 13(1):155-73. PubMed ID: 24308576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
    Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA
    Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
    Ribeiro SP; De Moura Mattaraia VG; Almeida RR; Valentine EJG; Sales NS; Ferreira LCS; Sa-Rocha LC; Jacintho LC; Santana VC; Sidney J; Sette A; Rosa DS; Kalil J; Cunha-Neto E
    Vaccine; 2022 Jan; 40(2):239-246. PubMed ID: 34961636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses.
    Rosa DS; Ribeiro SP; Almeida RR; Mairena EC; Postól E; Kalil J; Cunha-Neto E
    PLoS One; 2011 Feb; 6(2):e16921. PubMed ID: 21347287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses.
    Bazhan SI; Karpenko LI; Ilyicheva TN; Belavin PA; Seregin SV; Danilyuk NK; Antonets DV; Ilyichev AA
    Mol Immunol; 2010 Apr; 47(7-8):1507-15. PubMed ID: 20189249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules.
    Ribeiro SP; Rosa DS; Fonseca SG; Mairena EC; Postól E; Oliveira SC; Guilherme L; Kalil J; Cunha-Neto E
    PLoS One; 2010 Jun; 5(6):e11072. PubMed ID: 20552033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
    Santra S; Liao HX; Zhang R; Muldoon M; Watson S; Fischer W; Theiler J; Szinger J; Balachandran H; Buzby A; Quinn D; Parks RJ; Tsao CY; Carville A; Mansfield KG; Pavlakis GN; Felber BK; Haynes BF; Korber BT; Letvin NL
    Nat Med; 2010 Mar; 16(3):324-8. PubMed ID: 20173754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
    Cardinaud S; Bouziat R; Rohrlich PS; Tourdot S; Weiss L; Langlade-Demoyen P; Burgevin A; Fiorentino S; van Endert P; Lemonnier FA
    AIDS; 2009 Sep; 23(15):1945-54. PubMed ID: 19644347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
    Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
    J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.
    Liu H; Shen W; Shu J; Kou Z; Jin X
    PLoS One; 2017; 12(9):e0184207. PubMed ID: 28863168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
    Mothe B; Hu X; Llano A; Rosati M; Olvera A; Kulkarni V; Valentin A; Alicea C; Pilkington GR; Sardesai NY; Rocafort M; Crespo M; Carrillo J; Marco A; Mullins JI; Dorrell L; Hanke T; Clotet B; Pavlakis GN; Felber BK; Brander C
    J Transl Med; 2015 Feb; 13():60. PubMed ID: 25879820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes.
    Qin K; Boppana S; Carlson JM; Fiore-Gartland A; Files J; Zeng J; Edberg J; Mailliard RB; Ochsenbauer C; Bansal A; Goepfert P
    J Virol; 2021 Jul; 95(16):e0016021. PubMed ID: 34076482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.